A Study of a New PET Scanner in People With Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The researchers are doing this study to test the capabilities of a new total-body PET scanner called the Biograph Vision Quadra. The researchers want to learn whether this scanner can produce better PET/CT images and provide more useful imaging information than standard PET/CT scanners.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjenci z rakiem płuc potwierdzonym badaniem patologicznym
- •Pacjenci z rakiem prostaty lub rakiem głowy i szyi
- •Pacjenci, którzy przychodzą na planowe badanie skanera PET w głównym ośrodku
- •Pacjenci w wieku 18 lat lub starsi
- •Pacjenci chętni do powrotu na drugie badanie 2-6 godzin po wstrzyknięciu substancji radioaktywnej
✗ Disqualifies
- •Pacjenci z klaustrofobią (lękiem przed zamkniętymi przestrzeniami)
- •Kobiety w ciąży lub karmiące piersią
- •Osoby poniżej 18 lat
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 8, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (7)
Memorial Sloan Kettering Basking Ridge (Consent Only)
Basking Ridge, United States
Memorial Sloan Kettering Monmouth (Consent Only)
Middletown, United States
Memorial Sloan Kettering Bergen (Consent Only )
Montvale, United States
Memorial Sloan Kettering Suffolk-Commack (Consent Only)
Commack, United States
Memorial Sloan Kettering Westchester (Consent Only)
Harrison, United States
Memorial Sloan Kettering Cancer Center
New York, United States
Memorial Sloan Kettering Nassau (Consent Only)
Rockville Centre, United States
Trial contact
Heiko Schoder, MD
John Humm, PhD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/9/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.